NCT00960622View on ClinicalTrials.gov

Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
HIV
Interventions
DRUG

Truvada

Truvada (tenofovir 300mg / emtricitabine 200mg) capsule once daily for 6 months

DRUG

Combivir

Continue on Combivir (150 mg of lamivudine, 300 mg of zidovudine) two tablets daily for 6 months

DRUG

Trizivir

Continue on Trizivir (300 mg of abacavir as abacavir sulfate, 150 mg of lamivudine, and 300 mg of zidovudine)

Trial Locations (1)

10025

St. Luke's-Roosevelt Hospital Center, New York

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

St. Luke's-Roosevelt Hospital Center

OTHER